Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

NCT: NCT07205367 · COMPLETED

NCT IDNCT07205367
StatusCOMPLETED
Start Date2025-01-06
Completion2025-11-07
SponsoriRhythm Technologies, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing all adverse events.

Frequently Asked Questions

What is Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II?

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II is a clinical trial registered under NCT07205367. Current status: COMPLETED.

What is the status of NCT07205367?

The current status of NCT07205367 (Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II) is: COMPLETED.

When did Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II start?

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II started on 2025-01-06.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.